Member Info for mattrs27

Can someone just confirm to me please if they can see the latest sp and live trading data?

My T212 screen has been frozen since 8.am for Hemo. All other screens functioning live.

Thx

I assume these 10 to 14k tranches going through as unknowns are "sells", which is suppressing the sp?

Would these be the warrants going through?

Thales to supply India with £350m worth of uk air defence missiles.

I was reading yesterday that the average spend for FDA approval is around 850m USD. I can't help but think he's going to need a serious backer before comp of Phase 3.

Is it financial announcement day?

The age old clash between the viewpoint of traders, and the viewpoint of investors.

Does anyone else have terrible price lag on t212for Hemo? Its the only share that does it. All my other shares are up to the minute correct. Hemo is way behind, most of the time...and I mean by up to 30 minutes or more. Its very annoying.

All in USD

Average cost of cancer patient treatment in the USA is circa 200k. This includes patient care over the period of treatment, and after care. Not just the specific treatment

Existing Figures for CAR T therapy costs are hard to find since it is mostly experimental

There are currently 5 Car T treatments with approval by the US FDA. They are in their infancy and development continues across the board due to Car T related rejection issues and for a small number of patients serious side effects. The efficacy generally of Car T is seen to be more effective than standard treatments, and has in some trials demonstrated a circa 80 percent positive outcome.

The leading light in Car T is Immatics. They have progressed this further than anyone else. Carried out more real world test than anyone else. on todays valuation, there market cap is 847 million.

Today Hemo has a cap of circa 80 million.

The big push is to improve the reliability of car t treatment, and assess its effectiveness against solid tumours. This work is very much in its infancy across the board.

Its a huge step to have the process operational away from their premise or direct scrutiny under trial conditions, so risk management is key when expanding in this way. They will need to be absolutely on top of operations over there, as a fail in Estonia would be potentially damaging. it requires micro management

On the up side, obviously positive outcomes, and the data more than the money, will be beyond belief. Fingers crossed for the Estonian conversations and agreement to move forward.

HedgeHogarth,

I'll accept the first 2 words and we'll leave it at that shall we.

I've had a very successful career dealing with high risk products. Things that will kill you if they go wrong. And the one thing I learned is that the most basic questions are always the most searching.

I've read plenty on here about how you'll never get back in at this price and that price. Emotionally driven hypothesis which today have been proved to be completely wrong. Because none of us can predict the future. This a reactionary business largely. Not a pro active one such that I am used to dealing with.

So my questions may seem clumsy and naïve to you. But that doesn't make them any more stupid than anyone elses. as today has proven.

So again. You're wrong.

How do you like your scones...with or without sultanas?

HedgeHogarth

Thanks for your trading update. Very informative. I sincerely hope its more accurate than your character assessment.

I will say this now only one more time.

You know nothing, literally nothing about me. Stop making it personal when I ask a question. I'm almost flattered you think I'm some big time trader. 'Ive never placed a short in my life!

I've asked some really basic questions, business related. Which is what this forum is about. I understand that emotions run high here. Its not like any other forum I am part of. I understand there's a lot of money in play for some, that intensifies the mindset. I'm a design engineer and investor. My world is maths and knowing how things work. Thats it...plain and simple. I'm an investor in Hemo. I have been for a while. And I increased my stake to represent 25 percent of my portfolio this morning. Now short of inviting you round for tea, will that do for you?

In other news, and just to maintain my focus, I just re read some of the science behind what Hemo are doing. If you're ever in doubt, its a great refresher of the brilliance in play.

OMG

Are you for real?

Its a little worrying when people I thought were learned in this start posting nonsense about me. Until now I kind of believed you.

I'm an investor. I bought more stock this morning!!!

Grow up.

Process Guy

Thanks.

I'm ignoring the other comment from whoever he is

Although still genuinely interested in someone explaining a valuation. thx

I feel like I'm in the Big Short.

I didn't get an answer re share volume, so can I progress it to someone who actually knows what they are talking about, giving an understanding of what and how this company is currently valued, and how it could be valued in the future? I'm interested in the mechanics of all of that. Many thanks.

How many Ordinary shares are available in circulation in total?

I'm surprised the BP news hasn't had a bigger effect? Am I reading that wrong?

Have I missed a communication? Anything official driving the rise at the moment?

Does anyone know where the link is for the presentation?

Many thanks

No, I was just after some data!

Numbers not words.

Its ok...I get it. Its not available yet.

Bbb11 et al

Thanks...I did read Haywain's comments...and everyone else's.

By efficacy, I mean clinical data...cell counts etc. Rates of decline. Data that can be taken from statistically high enough sample groups (not patients, blood samples for eg). But you've answered the question re the actual data release and who is controlling that, so thanks. That's the information that I was looking for.

Some of you others need to drink less coffee!

Mr Jinx...you're a funny guy. We'll have to talk statistical analysis some time, and lemon farming.